NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 7 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Kriti Nutrients Limited has submitted its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th September 2026. For H1 FY27, the company reported a standalone profit before tax of ₹19.69 crore (1,968.52 lakh) compared to ₹45.11 crore for full-year FY26. Cash flow from operating activities saw a net outflow of ₹13.35 crore (1,334.50 lakh) during the half year, driven by working capital changes, particularly in other financial assets and inventories. Short-term borrowings stood at ₹8.02 crore (802.07 lakh) as of September 30, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of unaudited standalone and consolidated financial statements along with the limited review report for Q2 and H1 FY27.
ஏன் இது முக்கியம்Provides half-yearly balance sheet and cash flow health for Kriti Nutrients, indicating a temporary drag on operating cash flows due to working capital expansion.
H1 Profit Before Tax: ₹19.69 cr (1,968.52 lakh)H1 Net Cash from Operations: -₹13.35 cr (-1,334.50 lakh)Short-term Borrowings: ₹8.02 cr (802.07 lakh)Capex (PPE & CWIP additions): ₹2.06 cr (206.21 lakh)
📅 குறுகிய காலம்Market will evaluate the underlying Q2 revenue and net profit figures once fully parsed, against the prior quarter revenue run-rate of ~₹247 crore.
📈 நீண்ட காலம்Limited structural impact from routine earnings disclosures, though maintaining positive cash flow conversion will be vital for supporting expansion.
⚠ அபாய எச்சரிக்கைகள்
Negative operating cash flow in H1 due to working capital absorption
Dependency on seasonal soya crop cycle and seed pricing volatility
👀 கவனிக்க வேண்டியவை
Track the detailed Q2 revenue and margin trajectory once the full table is released, and monitor how working capital unwinds into operating cash flow in H2 FY27.
Kriti Nutrients Limited approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. For H1 FY27, standalone profit before tax reached ₹1,968.52 lakhs (₹19.69 Cr), down from ₹4,511.03 lakhs in the previous corresponding period. Net operating cash flow for H1 stood at a negative ₹1,334.56 lakhs (₹13.35 Cr), heavily impacted by working capital changes, particularly an increase in other financial assets. The statutory auditors issued an unmodified review report.
உச்சம் நம்பிக்கை
என்ன மாறியதுKriti Nutrients approved and published its standalone and consolidated financial results and balance sheet for Q2 and H1 FY27.
ஏன் இது முக்கியம்Provides updated operational performance metrics and cash flow trends; H1 profitability shows contraction relative to the previous year's pre-tax profit base.
H1 FY27 Standalone Profit Before Tax: ₹1,968.52 லட்சம்H1 FY27 Net Operating Cash Flow: ₹(1,334.56) lakhsShort-term Borrowings (Sep 30, 2026): ₹802.07 லட்சம்Short-term Borrowings (Mar 31, 2026): ₹755.98 லட்சம்
📅 குறுகிய காலம்The stock may trade in line with broad edible oil segment trends as markets digest the H1 pre-tax profit contraction.
📈 நீண்ட காலம்Performance will depend on geographic penetration into Rajasthan and UP and margin expansion through value-added soya products.
⚠ அபாய எச்சரிக்கைகள்
Negative operating cash flow of ₹13.35 Cr in H1 FY27 due to working capital swings
Dependency on seasonal soya crop cycles and raw material price volatility
👀 கவனிக்க வேண்டியவை
Track the detailed line-item quarterly revenue and margin progression in the full release, and monitor operational cash flow recovery in H2.
Q1 FY27 Results: Revenue up 7.9% YoY to ₹247.08 Cr; Consolidated PAT at ₹8.92 Cr
Kriti Nutrients reported a 7.9% YoY increase in revenue to ₹247.08 Cr for the quarter ended June 30, 2026. Consolidated Net Profit declined by 6% YoY to ₹8.92 Cr, down from ₹9.49 Cr in Q1 FY26, primarily due to higher stock-in-trade purchases and finance costs. However, on a sequential basis, profitability improved significantly by 40% compared to the ₹6.36 Cr reported in Q4 FY26. The company maintains a very low debt-to-equity ratio of 0.04, providing a stable financial base despite thin operating margins.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned into the new fiscal year (FY27) with moderate top-line growth but faces slight margin compression compared to the previous year's first quarter.
ஏன் இது முக்கியம்As a leader in the branded refined soya oil segment in Central India, the company's performance is a bellwether for consumer demand and raw material pricing in the solvent extraction industry.
Revenue (Q1 FY27): ₹247.08 கோடிConsolidated PAT (Q1 FY27): ₹8.92 கோடிYoY Revenue Growth: 7.87%QoQ PAT Growth: 40.25%Debt-to-Equity Ratio: 0.04
📅 குறுகிய காலம்The stock may see neutral movement as the market weighs the healthy sequential profit recovery against the slight year-on-year decline in earnings.
📈 நீண்ட காலம்Long-term value creation depends on increasing the share of high-margin value-added products in food and pharma categories and reducing geographic concentration.
⚠ அபாய எச்சரிக்கைகள்
Raw material price volatility (soya seeds)
Geographic concentration in Central India
Thin operating margins (4.7% TTM)
👀 கவனிக்க வேண்டியவை
Monitor the company's ability to pass on raw material price increases in the soya meal segment and the execution of its expansion into Rajasthan and Uttar Pradesh.
Kriti Nutrients Limited has submitted its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The statutory auditors, M Mehta & Company, have issued an unmodified opinion, confirming that the financial statements provide a true and fair view of the company's performance. The Board of Directors approved these results in a meeting held on May 5, 2026, which concluded at 5:10 P.M. While the specific numerical data table was not included in this cover letter, the clean audit report is a positive sign for financial transparency.
முக்கிய அம்சங்கள்
Audited standalone and consolidated financial results for FY 2025-26 approved on May 5, 2026.Statutory auditors issued a clean/unmodified opinion with no qualifications or modifications.Board meeting for result approval commenced at 2:30 P.M. and concluded at 5:10 P.M.Results prepared in full compliance with Ind AS and SEBI Regulation 33(3)(d).Company is in the process of filing results in XBRL format and publishing in English and Hindi newspapers.
👀 கவனிக்க வேண்டியவை
Investors should review the detailed Profit & Loss and Balance Sheet statements once the full numerical tables are available to assess revenue and margin growth. The clean audit report confirms the reliability of the company's financial reporting for the fiscal year.
Kriti Nutrients Board Recommends No Dividend for FY 2025-26
Kriti Nutrients Limited has announced that its Board of Directors, in a meeting held on May 5, 2026, decided not to recommend any final dividend for the financial year 2025-26. This follows a prior notification on April 28, 2026, where the board had scheduled a meeting to consider a potential dividend payout. The company's equity shares have a face value of Re. 1 each. The decision to skip the dividend suggests a focus on capital preservation or reinvestment of profits back into the business operations.
முக்கிய அம்சங்கள்
Board of Directors met on May 5, 2026, to discuss dividend recommendation for FY 2025-26.No final dividend recommended for equity shares with a face value of Re. 1/- each.The announcement follows a previous intimation of dividend consideration dated April 28, 2026.Decision reflects a shift in capital allocation strategy for the 2025-26 financial year.
👀 கவனிக்க வேண்டியவை
Investors should review the upcoming full-year financial results to understand the company's cash flow position and reasons for skipping the dividend. Monitor management commentary for any planned capital expenditures or debt reduction that may justify the retention of earnings.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Kriti Nutrients Re-appoints Shiv Singh Mehta as CMD; Elevates Saurabh Mehta to JMD
Kriti Nutrients has announced the re-appointment of Shri Shiv Singh Mehta as Chairman and Managing Director for a three-year term starting January 2027. Simultaneously, Mr. Saurabh Singh Mehta has been re-designated as Joint Managing Director effective May 5, 2026, with a further three-year term approved from August 2027. These appointments ensure leadership continuity for the company, which is part of the Rs. 1,500 crore turnover Kriti Group. The decisions are subject to shareholder approval at the next General Meeting.
முக்கிய அம்சங்கள்
Shri Shiv Singh Mehta re-appointed as CMD for 3 years effective Jan 12, 2027.Mr. Saurabh Singh Mehta elevated to Joint Managing Director (JMD) effective May 5, 2026.Saurabh Singh Mehta's tenure as JMD extended for 3 years starting Aug 1, 2027.The Kriti Group reports an aggregate annual turnover of approximately Rs. 1,500 crore.Appointments are pending final approval from members in the ensuing General Meeting.
👀 கவனிக்க வேண்டியவை
The re-appointments suggest a continuation of the current strategic direction under the existing promoter family. Investors should monitor the company's performance consistency under this stable leadership.
Kriti Nutrients FY26 Results: Board Skips Final Dividend, Re-appoints MD for 3 Years
Kriti Nutrients has approved its audited financial results for the quarter and year ended March 31, 2026. The Board has notably decided not to recommend any final dividend for the financial year 2025-26, which may impact short-term investor sentiment. To ensure leadership continuity, the company re-appointed Mr. Shiv Singh Mehta as Chairman and Managing Director for a three-year term starting in 2027. Additionally, Mr. Saurabh Singh Mehta has been elevated to the position of Joint Managing Director.
முக்கிய அம்சங்கள்
Audited standalone and consolidated financial results for FY26 approved with an unmodified auditor opinion.No final dividend recommended for the financial year 2025-26 on equity shares of Re. 1/- each.Mr. Shiv Singh Mehta re-appointed as Chairman and MD for a 3-year term effective January 12, 2027.Mr. Saurabh Singh Mehta re-designated as Joint Managing Director with a new 3-year term starting August 2027.The Board meeting concluded with a focus on management stability and routine business agendas.
👀 கவனிக்க வேண்டியவை
Investors should analyze the full financial statements to understand why the dividend was skipped despite the audited profits. The management continuity is a positive sign for long-term strategic execution.
Kriti Nutrients Shareholders Approve MOA Changes for Solar Power with 99.96% Majority
Kriti Nutrients Limited has received shareholder approval to amend its Memorandum and Articles of Association to include power generation activities. This strategic move allows the company to establish solar power facilities for captive use, following directions from the Madhya Pradesh Power Transmission Company Limited. The resolutions were passed with a near-unanimous majority of 99.9555% during the EGM held on March 20, 2026. This initiative is expected to enhance energy efficiency and reduce long-term power costs for the company's manufacturing operations.
முக்கிய அம்சங்கள்
Special resolution passed to add Clause 35A to the MOA, enabling the company to generate and distribute power from renewable sources like solar and wind.The proposal received 3,34,19,621 votes (99.9555%) in favor, indicating strong shareholder support for the green energy transition.The initiative focuses on captive power generation to meet requirements set by the Madhya Pradesh Power Transmission Company Limited.The EGM was conducted via video conferencing with 47 members participating, comfortably meeting the quorum requirement of 30.
👀 கவனிக்க வேண்டியவை
This is a positive development for long-term cost management; investors should track the implementation timeline and capital expenditure involved in the solar power setup.
Kriti Nutrients Approves MOA and AOA Changes to Enter Power Generation Sector
Kriti Nutrients Limited conducted an Extraordinary General Meeting (EGM) on March 20, 2026, to approve significant changes to its business objects. Shareholders voted on altering the Memorandum and Articles of Association to permit the company to engage in power generation from conventional and renewable sources like solar and wind. This strategic move enables the company to establish power plants for both captive consumption and commercial sale. The meeting saw participation from 47 members, and the final voting results will be disclosed within two working days.
முக்கிய அம்சங்கள்
EGM held on March 20, 2026, with 47 members present, meeting the quorum requirement of 30.Approved insertion of Clause 35A in the MOA to include power generation, transmission, and distribution.Authorized the Board via new Article 92 in the AOA to acquire or manage electricity generation plants.Scope includes diverse energy sources such as solar, wind, biomass, and hydrogen for captive or external use.Voting results to be declared within 2 working days from the meeting conclusion.
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming voting results and look for management commentary on planned CAPEX for power infrastructure. This move suggests a focus on operational efficiency through captive power and potential diversification into the energy sector.
Kriti Nutrients to Seek Shareholder Approval for Power Generation Business Expansion at EGM
Kriti Nutrients Limited has scheduled an Extra Ordinary General Meeting (EGM) on March 20, 2026, to seek shareholder approval for significant amendments to its Memorandum and Articles of Association. The company intends to expand its business scope to include the generation, distribution, and sale of power from conventional and renewable sources such as solar, wind, and biomass. This move allows the company to establish power plants for both captive consumption to reduce operational costs and for commercial sale to external parties. The meeting will be conducted via video conferencing, reflecting a strategic pivot towards energy infrastructure.
முக்கிய அம்சங்கள்
EGM scheduled for March 20, 2026, to approve alterations in the Memorandum of Association (MOA) and Articles of Association (AOA).Proposed insertion of Clause 35A in MOA to enable business in solar, wind, biomass, and hydrogen energy sectors.New Article 92 to be added to AOA, authorizing the Board to acquire or build power facilities for captive or commercial use.The expansion covers a wide range of technologies including thermal, hydel, and fuel cell technology.Facility for participation at the EGM through VC/OAVM will be available for up to 1,000 members.
👀 கவனிக்க வேண்டியவை
Investors should view this as a strategic move towards energy self-sufficiency and potential revenue diversification; monitor future announcements regarding specific CAPEX for power projects.
Kriti Nutrients Q3 FY26 Consolidated Net Profit Rises 11% YoY to ₹9.16 Crore
Kriti Nutrients reported a strong 29.7% YoY growth in consolidated revenue for Q3 FY26, reaching ₹224.31 crore. Consolidated net profit for the quarter grew by 11% YoY to ₹9.16 crore, showing recovery from previous quarters. However, the nine-month (9M) profit remains 14.1% lower than the previous year at ₹27.54 crore, reflecting margin pressures earlier in the fiscal year. The company maintains a stable balance sheet with minimal finance costs of ₹11.75 lakhs for the quarter.
முக்கிய அம்சங்கள்
Consolidated Revenue from Operations grew 29.7% YoY to ₹224.31 crore in Q3 FY26.Consolidated Net Profit increased 11% YoY to ₹9.16 crore from ₹8.25 crore in Q3 FY25.9M FY26 Revenue reached ₹666.28 crore, up 24.7% compared to ₹534.28 crore in 9M FY25.Cost of materials consumed rose significantly to ₹181.85 crore in Q3 FY26 vs ₹135.80 crore in Q3 FY25.Consolidated EPS for the quarter improved to ₹1.83 from ₹1.65 in the year-ago period.
👀 கவனிக்க வேண்டியவை
The quarterly performance shows healthy top-line growth and a recovery in bottom-line margins compared to the previous quarter. Investors should monitor raw material price trends as they remain the largest cost component impacting overall profitability.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
